Evaluation of different serological diagnostic methods for tick-borne encephalitis virus: Enzyme-linked immunosorbent, immunofluorescence, and neutralization assay

Vector-Borne and Zoonotic Diseases

Volumn 14, Issue 2, 2014, Pages 149-159

  Litzba, Nadine ^a   Zelená, Hana ^b   Kreil, Thomas R ^c   Niklasson, Bo ^d   Kühlmann Rabens, Ilona ^e   Remoli, Maria Elena ^f   Niedrig, Matthias ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b Zdravotniho ustavu se sidlem v Ostrave   (Czech Republic)

^c BAXTER BIOSCIENCE   (Austria)

^d UPPSALA UNIVERSITY   (Sweden)

^e Institut Virion/Serion GmbH   (Germany)

^f ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Enzyme linked immunosorbent assays; External quality assessment; Immunofluorescence assay; Neutralization test; Tick borne encephalitis virus

Indexed keywords

ANTIBODIES, VIRAL; CROSS REACTIONS; DENGUE; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPE; FLAVIVIRUS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN G; LABORATORY PROFICIENCY TESTING; NEUTRALIZATION TESTS;

EID: 84894208738     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2012.1287     Document Type: Article

References (19)

1. Castro AR Kikkert SE Fears MB Pope V. Defibrination of blood plasma for use in serological tests for syphilis. Clin Diagn Lab Immunol 2002;9:1376-1378. (Pubitemid 35283308)
2. Ecker M Allison SL Meixner T Heinz FX. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 1999; 80(Pt 1):179-185. (Pubitemid 29041696)
3. Fritz R Orlinger KK Hofmeister Y Janecki K et al. Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes. Vaccine 2012; 30:1165-1169.
4. Gritsun TS Frolova TV Zhankov AI Armesto M et al. Characterization of a Siberian virus isolated from a patient with progressive chronic tick-borne encephalitis. J Virol 2003; 77: 25-36. (Pubitemid 36004943)
5. Hofmann H Heinz FX Dippe H. ELISA for IgM and IgG antibodies against tick-borne encephalitis virus: Quantification and standardization of results. Zentralbl Bakteriol Mikrobiol Hyg A 1983; 255:448-455. (Pubitemid 14195780)
6. Hofmann H. Frühsommer-Meningoenzephalitis (FSME) Was muss der Hausarzt wissen? Hausarzt 2005; 3:21-27.
7. Holzmann H Kundi M Stiasny K Clement J et al. Correlation between ELISA hemagglutination inhibition and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol 1996; 48:102-107. (Pubitemid 26144865)
8. Holzmann H. Diagnosis of tick-borne encephalitis. Vaccine 2003; 21(Suppl 1):S36-S40.
9. Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: A prospective study of 656 patients. Brain 1999; 122(Pt 11):2067-2078.
10. Kaiser R. Tick-borne encephalitis: Clinical findings and prognosis in adults. Wien Med Wochenschr 2012; 162:239-243.
11. Kiessig ST Abel U Risse P Friedrich J et al. Problems of cut-off level determination in enzyme immunoassays: The case of TBE-ELISA. Klin Lab 1993; 39:877-886. (Pubitemid 23349774)
12. Kollaritsch H Krasilnikov V Holzmann H Karganova G et al. Background Document on Vaccines and Vaccination against Tick-borne Encephalitis (TBE). Geneva: WHO; 2011. Available at www.who.int/immunization/sage/6-TBE-backgr-18- Mar- net-Apr-2011.pdf Last accessed October 13 2013.
13. Kunz C. TBE vaccination and the Austrian experience. Vaccine 2003; 21(Suppl 1):S50-S55.
14. Linscott WD Levinson WE. Complement components required for virus neutralization by early immunoglobulin antibody. Proc Natl Acad Sci USA 1969;64:520-527.
15. Mehlhop E Fuchs A Engle M Diamond MS. Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism. Virology 2009; 393:11-15.
16. Mozdzanowska K Feng J Eid M Zharikova D Gerhard W. Enhancement of neutralizing activity of influenza virusspecific antibodies by serum components. Virology 2006;352: 418-426. (Pubitemid 44216008)
17. Roehrig JT Hombach J Barrett AD. Guidelines for plaquereduction neutralization testing of human antibodies to dengue viruses. Viral Immunol 2008; 21:123-132. (Pubitemid 351873374)
18. Thomas SJ Nisalak A Anderson KB Libraty DH et al. Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance. Am J Trop Med Hyg 2009; 81:825-833.
19. World Health Organization. Vaccines against tick-borne encephalitis: WHO position paper-recommendations. Vaccine 2011; 29:8769-8770.